title: Structural aspects of activation pathways of aspartic protease zymogens and viral 3C protease precursors.
abstract: The three-dimensional structures of the inactive protein precursors (zymogens) of the serine, cysteine, aspartic, and metalloprotease classes of proteolytic enzymes are known. Comparisons of these structures with those of the mature, active proteases reveal that, in general, the preformed, active conformations of the residues involved in catalysis are rendered sterically inaccessible to substrates by the residues of the zymogens' N-terminal extensions or prosegments. The prosegments interact in nonsubstrate-like fashions with the residues of the active sites in most of the cases. The gastric aspartic proteases have a well-characterized zymogen conversion pathway. Structures of human progastricsin, the inactive intermediate 2, and active human pepsin are known and have been used to define the conversion pathway. The structure of the zymogen precursor of plasmepsin II, the malarial aspartic protease, shows a new twist on the mode of inactivation used by the gastric zymogens. The prosegment of proplasmepsin disrupts the active conformation of the two catalytic aspartic acid residues by inducing a major reorientation of the two domains of the mature protease. The picornaviral 2A and 3C proteases have a chymotrypsin-like tertiary structure but with a cysteine nucleophile. These enzymes cleave themselves from the viral polyprotein in cis (intramolecular cleavage) and carry out trans cleavages of other scissile peptides important for the virus life cycle. Although the structure of the precursor viral polyprotein is unknown, it probably resembles the organization of the proenzymes of the bacterial serine proteases, subtilisin, and alpha-lytic protease. Cleavage of the prosegment is known to occur in cis for these precursor molecules.
authors.affiliation: Medical Research Council Group in Protein Structure and Function, Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada.
authors.forename: A R
authors.initials: AR
authors.lastname: Khan
authors.forename: N
authors.initials: N
authors.lastname: Khazanovich-Bernstein
authors.forename: E M
authors.initials: EM
authors.lastname: Bergmann
authors.forename: M N
authors.initials: MN
authors.lastname: James
mesh_terms: D000086042:3C Viral Proteases; D000818:Animals; D016282:Aspartic Acid Endopeptidases / Q000737:chemistry* / Q000378:metabolism; D002384:Catalysis; D003546:Cysteine Endopeptidases / Q000737:chemistry* / Q000378:metabolism; D004789:Enzyme Activation; D004792:Enzyme Precursors / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D010434:Pepsin A / Q000737:chemistry* / Q000378:metabolism; D020115:Pepsinogen C / Q000737:chemistry* / Q000378:metabolism; D015800:Protozoan Proteins; D014764:Viral Proteins
chemical_list: D004792:Enzyme Precursors; D015800:Protozoan Proteins; D014764:Viral Proteins; D020115:Pepsinogen C; D003546:Cysteine Endopeptidases; D000086042:3C Viral Proteases; D016282:Aspartic Acid Endopeptidases; C116755:proplasmepsin II; D010434:Pepsin A; C020557:gastricsin; C100637:plasmepsin II